it is a good healthcare business imo. good private hospital contracts, and it is in the right demographics. similar to listed CAJ but this is different as its more in private hospitals where the cases are more complex(hence greater need for radiology). Good organic capacity expansion and some bolt on / roll ups possible.
the range is 15-18 p/e so lower in the range will offer greater upside. CAJ is currently trading at 18x, the top of the range of IDX, but has been listed long time and has high quality metro locations like NSW/Sydney which are premium.
One benefit of IDX over CAJ is the greater dividend, around 4%ff with a much better payout ratio than CAJ. CAJ's is only around 2.8%ff, so theres a solid 10-15% premium likely on listing depending on the price as fundies chase defensive health exposure with a good yield(in a weaker macro environment ,defensives will shield the portfolios).
